Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04583891 · ClinicalTrials.gov registry record · NA

Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design

A NA study, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
313
Enrollment target

NCT04583891 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 313 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04583891, a NA study, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
313 participants
Enrollment target

Study Summary

The overarching goals of this project are to provide the first rigorous test of a scalable and publicly accessible mobile health intervention (IntelliCare) to address emotional distress in women with breast cancer, and to test the impact of human coaching as a way to increase engagement with digital health interventions to improve outcomes. To achieve these goals, an innovative experimental study design, known as a Sequential, Multiple Assignment, Randomized Trial (SMART), will be used to test the effects of the IntelliCare apps on symptoms of depression and anxiety, as well as the added value of human support to improve participant engagement. 313 breast cancer survivors diagnosed within the past 5 years and who screen positive for elevated symptoms of depression and/or anxiety will be recruited. Participants will initially be randomized to receive the IntelliCare apps or app-delivered patient education (control) for 8 weeks, and the impact of the IntelliCare apps on reducing symptoms of depression and anxiety in breast cancer survivors relative to control will be tested (Aim 1). We will monitor the app usage data of participants who receive the IntelliCare apps. Those who are high-engagers will continue to use the apps with no change. Those who are low-to-moderate engagers will be rerandomized after 1 week to either receive added coaching vs. not (i.e., no change) in addition to the apps. The hypothesis is that added coaching to address barriers to app usage will lead to greater engagement with the apps (Aim 2), for low-to-moderate engagers. Finally, semi-structured exit interviews will be conducted with participants that receive the IntelliCare apps and coaching. Interviews will capture survivors' perceptions about the extent to which, and how, tailoring the apps and coaching specifically for breast cancer survivors may improve intervention outcomes and engagement (Aim 3).

Interventions

  • BEHAVIORAL Psychoeducation
  • BEHAVIORAL IntelliCare
  • BEHAVIORAL Coaching

Trial Details

FieldValue
Enrollment Target 313 participants
Start Date 2021-09-27
Est. Completion 2024-01-16
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT04583891

The ClinicalTrials.gov registry entry for NCT04583891 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 313 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Psychoeducation is the first listed.

NCT04583891 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04583891 about?

NCT04583891 is a clinical study titled "Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design". The overarching goals of this project are to provide the first rigorous test of a scalable and publicly accessible mobile health intervention (IntelliCare) to address emotional distress in women with breast cancer, and to test the impact of human coaching as a way to increase engagement with digital...

What is the current status of trial NCT04583891?

This trial is currently completed. It is a NA study. The enrollment target is 313 participants. The study started on 2021-09-27. Estimated completion is 2024-01-16.

What interventions are being tested in trial NCT04583891?

The interventions under investigation include: Psychoeducation (BEHAVIORAL), IntelliCare (BEHAVIORAL), Coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT04583891?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.